Caris Life Sciences president sold stock in broker-assisted options exercise
Officer David Baxley Spetzler sold Caris Life Sciences common stock in a broker-assisted sell-to-cover of fully vested stock options. Weighted average sale prices were $24.7604, $25.3201 and $24.7552 per share.
David Baxley Spetzler, an officer serving as President, reported sales of Caris Life Sciences common stock effected in a broker-assisted sell-to-cover exercise of fully vested stock options.
The transactions were reported at weighted average prices of $24.7604, $25.3201 and $24.7552 per share.
The…